Zydus Lifesciences on Tuesday said it will undertake development of a combination vaccine against shigellosis and typhoid.

Zydus Lifesciences to develop first combination vaccine for typhoid and shigellosis with Gates Foundation support.

Leveraging its World Health Organization (WHO)-prequalified Typhoid Conjugate Vaccine (ZyVac TCV) and a Shigella vaccine from ...

Severe Shigella cases — also known as dysentery — can be fatal, though the bacterial strains now circulating in Oregon tend to cause milder illness.

The surge in Portland of the extremely contagious bacterial illness is linked to the number of people experiencing ...

A highly contagious disease is alarmingly on the rise in one US state. Cases of dysentery, also called shigellosis, are ...

Typhoid is already a disease of concern globally and various endemic countries already have TCV as part of their national ...

The airport became operational, there has been consistent demand for flights, with many residents appreciating its modern ...

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the U.S. Food and Drug Administration (FDA) has ...

A rise in dysentery cases, particularly shigellosis, has been reported in Portland, Oregon, affecting vulnerable populations ...